Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPK14 | Q16539 | 7/20 | 0.77 |
| ▸ | RAB9A | P51151 | 3/20 | 0.50 |
| ▸ | MEN1 | O00255 | 2/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.50 |
| ▸ | PRKACA | P17612 | 1/20 | 0.50 |
| ▸ | ROCK1 | Q13464 | 1/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.43 |
| ▸ | HTT | P42858 | 1/20 | 0.43 |
| ▸ | CCNA2 | P20248 | 1/20 | 0.43 |
| ▸ | CDK2 | P24941 | 1/20 | 0.43 |
| ▸ | CCNA1 | P78396 | 1/20 | 0.43 |
| ▸ | ELOVL1 | Q9BW60 | 2/20 | 0.42 |
| ▸ | LMNA | P02545 | 3/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6176676 | 0.91 | MAPK14 (0.76) | MAPK14RAB9AMEN1KMT2APRKACA | |
| SCHEMBL6175320 | 0.90 | MAPK14 (0.74) | MAPK14RAB9AMEN1KMT2APRKACA | |
| SCHEMBL6193971 | 0.88 | MAPK14 (0.72) | MAPK14MEN1KMT2AROCK1 | |
| SCHEMBL6177800 | 0.87 | MAPK14 (1.00) | MAPK14PRKACAROCK1ALDH1A1CCNA2 | |
| SCHEMBL6178765 | 0.87 | MAPK14 (0.71) | MAPK14RAB9AMEN1KMT2AALDH1A1 | |
| SCHEMBL6178962 | 0.86 | MAPK14 (0.89) | MAPK14KMT2APRKACAROCK1CDK2 | |
| SCHEMBL6180514 | 0.86 | MAPK14 (0.89) | MAPK14MEN1KMT2APRKACAROCK1 | |
| SCHEMBL6177992 | 0.85 | MAPK14 (0.73) | MAPK14 | |
| SCHEMBL6176666 | 0.84 | MAPK14 (0.76) | MAPK14RAB9AMEN1KMT2AALDH1A1 | |
| SCHEMBL6176270 | 0.84 | MAPK14 (0.75) | MAPK14MEN1KMT2APRKACAROCK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1142890-B1 | AMINOPYRAZOLE DERIVATIVES | TEIKOKU HORMONE MFG CO LTD (JP) | 2005-08-03 | — | — | EP | disclosed |
| US-6511997-B1 | For treatment of a disease associated with tumor necrosis factor alpha, interleukin 1, interleukin 6 or cyclooxygenase II; such as irritable bowel disease | TEIKOKU HORMONE MFG. CO., LTD. (JP) | 2003-01-28 | — | — | US | disclosed |
| EP-1142890-A1 | AMINOPYRAZOLE DERIVATIVES | TEIKOKU HORMONE MFG. CO., LTD. (JP) | 2001-10-10 | — | — | EP | disclosed |